Sponsors (7)
Official title: To amend the Public Health Service Act to provide for a public awareness campaign with respect to human papillomavirus, and for other purposes.
Introduced December 10, 2025 by Kathy Castor · Last progress December 10, 2025
The bill directs substantial, multi-year federal investment to expand HPV vaccination outreach and women's cancer screening—likely improving prevention, equity, and public-health capacity—but does so at meaningful federal cost, with implementation burdens, limited outreach funding, and risks to continuity and accountability if oversight or future funding fall short.
Women and patients: provides $300 million/year (FY2026–2030) and improved program coordination to expand breast and cervical cancer screening, increasing early detection and likely reducing late-stage disease and mortality.
Adolescents and the broader population: establishes a named federal initiative and promotes HPV vaccination (especially ages 9–12), which should raise vaccination rates and reduce future HPV-related cancers for both sexes, lowering long-term treatment costs.
Public health capacity: authorizes federal grants and multi-year mandatory funding to state, local, and Tribal health departments and nonprofits, giving predictable resources for outreach, coordination with screening programs, and program planning.
Taxpayers and the federal budget: the bill increases federal spending substantially (approximately $300M/year for screening plus additional annual outreach funding), totaling roughly $1.5 billion or more over FY2026–2030, which could increase deficits or require offsets.
Implementation costs and provider burden: public health programs, insurers, and clinicians may face added costs and administrative workload to run outreach, counseling, reminder systems, and vaccine delivery, shifting burdens onto providers and payers.
Governance and access risks: if coordinating committee edits reduce stakeholder input or the bill's vaccination focus is not paired with concrete access measures, program effectiveness, accountability, and equitable access—especially in underserved areas—could suffer.
Based on analysis of 4 sections of legislative text.
Creates a CDC-run national HPV awareness campaign with $5M/year (2026–2030) and adds $300M/year (2026–2030) for the Breast and Cervical Cancer Early Detection Program.
Creates a federally led HPV cancer prevention effort by directing CDC to run a national public awareness campaign to increase HPV vaccination, fight misinformation, and improve screening outreach, with grants to nonprofits and health departments and $5 million per year authorized for 2026–2030. It also provides new mandatory funding—$300 million per year for 2026–2030—for the Breast and Cervical Cancer Early Detection Program and makes unspecified technical edits to a coordinating committee provision.